Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

P Tau

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



Out of the shadows - Living with dementia

parkinson's drug2 - against alzheimer's disease1 - uncategorized1 - developing alzheimers2 - thinking abilities1 - care or dementia1 - alcohol consumption1 - dopamine levels1 - dementia workers1 - abeta1 - early-stage parkinsons1 - mild alzheimer's stage1 - management of delirium1 - harvard medical school1 - non-familial parkinson's1 - alzheimer’s patients1 - dysarthria1 - baroness thatcher1 - boissier de sauvages2 - amyloid beta 42 peptide1 - amyloid beta8 - aids related dementia1 - genetic evidence1 - methamphetamine1 - aricept1 - late-onset alzheimer's2 - dementia135 - app3 - foolishness1 - mid-life factors1 -